The United States intensity-modulated proton therapy market represents the largest share of the North American region, driven by a high cancer burden, substantial healthcare expenditure, and rapid adoption of innovative cancer treatment technologies. The country has a growing network of proton therapy centers equipped with advanced treatment planning and imaging systems, enabling wider access...